Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells

Biochemical Journal

Volumn 447, Issue 1, 2012, Pages 71-79

  Ferrand, Nathalie ^a,b,c   Stragier, Emilien ^b,c,d   Redeuilh, Gérard ^a,b,c   Sabbah, Michèle ^a,b,c  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

Breast cancer; Cysteine rich 61 connective tissue growth factor nephroblastoma overexpressed 5 (ccn5) wnt1 (wingless type mmtv integration site family, member 1) inducible signalling pathway protein 2 (wisp 2); Epithelium; Glucocorticoid; Mesenchyme; Oestrogen

Indexed keywords

CADHERIN; CADHERIN 11; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH 61 CONNECTIVE TISSUE GROWTH FACTOR NEPHROBLASTOMA OVEREXPRESSED 5 PROTEIN; CYSTEINE RICH PROTEIN 61; DEXAMETHASONE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIMENTIN; WINGLESS TYPE MMTV INTEGRATION SITE FAMILY MEMBER 1 INDUCIBLE SIGNALLING PATHWAY PROTEIN 2; ZINC FINGER E BOX BINDING HOMEOBOX 1 PROTEIN; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CCN INTERCELLULAR SIGNALING PROTEINS; CELL LINE, TUMOR; DEXAMETHASONE; DNA PRIMERS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

MOUSE MAMMARY TUMOR VIRUS;

EID: 84866386719     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120311     Document Type: Article

References (42)

1. Brigstock, D. R. (2003) The CCN family: a new stimulus package. J. Endocrinol. 178, 169-175
2. Brigstock, D. R., Goldschmeding, R., Katsube, K. I., Lam, S. C., Lau, L. F., Lyons, K., Naus, C., Perbal, B., Riser, B., Takigawa, M. and Yeger, H. (2003) Proposal for a unified CCN nomenclature. Mol. Pathol. 56, 127-128
3. Brigstock, D. R. (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20, 189-206
4. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M. et al. (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U.S.A. 95, 14717-14722
5. Mason, H. R., Lake, A. C., Wubben, J. E., Nowak, R. A. and Castellot, Jr, J. J. (2004) The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol. Hum. Reprod. 10, 181-187
6. Dhar, G., Mehta, S., Banerjee, S., Gardner, A., McCarty, B. M., Mathur, S. C., Campbell, D. R., Kambhampati, S. and Banerjee, S. K. (2007) Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Cancer Lett. 254, 63-70
7. Davies, S. R., Davies, M. L., Sanders, A., Parr, C., Torkington, J. and Jiang, W. G. (2010) Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int. J. Oncol. 36, 1129-1136
8. Banerjee, S., Saxena, N., Sengupta, K., Tawfik, O., Mayo, M. S. and Banerjee, S. K. (2003) WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5, 63-73
9. Fritah, A., Redeuilh, G. and Sabbah, M. (2006) Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens. J. Endocrinol. 191, 613-624
10. Inadera, H., Hashimoto, S., Dong, H. Y., Suzuki, T., Nagai, S., Yamashita, T., Toyoda, N. and Matsushima, K. (2000) WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275, 108-114
11. Fritah, A., Saucier, C., De Wever, O., Bracke, M., Bieche, I., Lidereau, R., Gespach, C., Drouot, S., Redeuilh, G. and Sabbah, M. (2008) Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol. Cell. Biol. 28, 1114-1123
12. De Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M. and Berx, G. (2008) Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130, 481-494
13. Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prevost, G., Zimber, A., Ouelaa, R., Bracke, M., De Wever, O. and Gespach, C. (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist. Updates 11, 123-151
14. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454
15. Yang, J. and Weinberg, R. A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829
16. Sabbah, M., Prunier, C., Ferrand, N., Megalophonos, V., Lambein, K., De Wever, O., Nazaret, N., Lachuer, J., Dumont, S. and Redeuilh, G. (2011) CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway. Mol. Cell. Biol. 31, 1459-1469
17. Dhar, G., Banerjee, S., Dhar, K., Tawfik, O., Mayo, M. S., Vanveldhuizen, P. J. and Banerjee, S. K. (2008) Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2. Cancer Res. 68, 4580-4587
18. Banerjee, S., Dhar, G., Haque, I., Kambhampati, S., Mehta, S., Sengupta, K., Tawfik, O., Phillips, T. A. and Banerjee, S. K. (2008) CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res. 68, 7606-7612
19. Banerjee, S. K. and Banerjee, S. (2012) CCN5/WISP-2: a micromanager of breast cancer progression. J. Cell Commun. Signal. 6, 63-71
20. Focan, C., Beauduin, M., Majois, F., Canon, J. L., Cusumano, G., Focan-Henrard, D. and Lobelle, J. P. (2004) High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update. Clin. Breast Cancer 5, 136-141
21. Otani, S., Toyota, N., Nozaka, K., Wakatsuki, T., Takebayashi, M., Kamasako, A., Tanida, O., Hashiguchi, H., Ohgami, Y. and Hirooka, Y. (2004) Successful combination therapy with 5′-DFUR and MPA for breast cancer with spinal and vertebral metastases. Gan To Kagaku Ryoho 31, 2151-2153
22. Zaucha, R., Sosinska-Mielcarek, K. and Jassem, J. (2004) Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate. Breast 13, 321-324
23. Fritah, A., Saucier, C., Mester, J., Redeuilh, G. and Sabbah, M. (2005) p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor α. Mol. Cell. Biol. 25, 2419-2430
24. Saxena, N., Banerjee, S., Sengupta, K., Zoubine, M. N. and Banerjee, S. K. (2001) Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines. Mol. Cell. Biochem. 228, 99-104
25. Wan, Y. and Nordeen, S. K. (2003) Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestins. Recent Prog. Horm. Res. 58, 199-226
26. Schoneveld, O. J., Gaemers, I. C. and Lamers, W. H. (2004) Mechanisms of glucocorticoid signalling. Biochim. Biophys. Acta 1680, 114-128
27. Newton, R. and Holden, N. S. (2007) Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol. Pharmacol. 72, 799-809
28. Oakley, R. H. and Cidlowski, J. A. (2011) Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 286, 3177-3184
29. Tsai, M. J. and O'Malley, B. W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486
30. Vilasco, M., Communal, L., Mourra, N., Courtin, A., Forgez, P. and Gompel, A. Glucocorticoid receptor and breast cancer. Breast Cancer Res. Treat. 130, 1-10
31. Dostert, A. and Heinzel, T. (2004) Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr. Pharm. Des. 10, 2807-2816
32. Borras, M., Hardy, L., Lempereur, F., el Khissiin, A. H., Legros, N., Gol-Winkler, R. and Leclercq, G. (1994) Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol. 48, 325-336
33. Shyamala, G., Schneider, W. and Guiot, M. C. (1992) Estrogen dependent regulation of estrogen receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity. Receptor 2, 121-128
34. Nieman, M. T., Prudoff, R. S., Johnson, K. R. and Wheelock, M. J. (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147, 631-644
35. Pishvaian, M. J., Feltes, C. M., Thompson, P., Bussemakers, M. J., Schalken, J. A. and Byers, S. W. (1999) Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 59, 947-952
36. Zhou, F., Bouillard, B., Pharaboz-Joly, M. O. and Andre, J. (1989) Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Mol. Cell. Endocrinol. 66, 189-197
37. Krishnan, A. V., Swami, S. and Feldman, D. (2001) Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 77, 29-37
38. Hall, R. E., Lee, C. S., Alexander, I. E., Shine, J., Clarke, C. L. and Sutherland, R. L. (1990) Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int. J. Cancer 46, 1081-1087
39. Lecanda, F., Cheng, S. L., Shin, C. S., Davidson, M. K., Warlow, P., Avioli, L. V. and Civitelli, R. (2000) Differential regulation of cadherins by dexamethasone in human osteoblastic cells. J. Cell Biochem. 77, 499-506
40. Wang, F., Hansen, Radisky, R. K., Yoneda, T., Barcellos-Hoff, M. E., Petersen, O.W., Turley, E. A. and Bissell, M. J. (2002) Phenotypic reversion or death of cancer cells by altering signalling pathways in three-dimensional contexts. J. Natl. Cancer Inst. 94, 1494-1503
41. Ouatas, T., Halverson, D. and Steeg, P. S. (2003) Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin. Cancer Res. 9, 3763-3772
42. Palmieri, D., Halverson, D. O., Ouatas, T., Horak, C. E., Salerno, M., Johnson, J., Figg, W. D., Hollingshead, M., Hursting, S., Berrigan, D. et al. (2005) Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J. Natl. Cancer Inst. 97, 632-642